Ohio Life Sciences

Shaping public policy is a key part of what we do at Ohio Life Sciences. Yesterday, our Director of Policy, Willa Bluestone, testified before the Senate Insurance Committee in support of House Bill 24, which would require health plan and Medicaid coverage of #biomarker testing. This bill highlights #Ohio’s leadership in life sciences and its commitment to getting innovative treatments to patients who need them. Thank you, Andrea White, our 2024 OLS Legislator of the Year, for championing this important work! #OhioLifeSciences #Advocacy #Innovation

?? Congratulations to OLS Member Investor Clarametyx Biosciences for being recognized as the "Infectious Disease Innovation of the Year" in the 2024 BioTech Breakthrough Awards! This well-deserved honor highlights the incredible progress behind their innovative anti-biofilm antibody approach targeting chronic respiratory diseases.

We want to give a big shoutout to 10?member investors honored on BioSpace’s "2025 Best Places to Work in Biopharma" list! Their dedication to fostering innovation, supporting employees, and driving meaningful change in the life sciences industry is inspiring. We’re proud to have such impactful organizations as part of our community. Eli Lilly and Company | Regeneron | Amgen | Novo Nordisk AbbVie | Gilead Sciences | BioMarin Pharmaceutical Inc. | CSL Resilience | Forge Biologics https://lnkd.in/gcafUtmT

Yesterday, we brought together life sciences employers, university leaders, and community college representatives to launch an innovative approach to connecting talent with opportunities in Ohio’s life sciences industry. This collaboration is a key step in building a stronger pipeline to support the growth and success of our field. Stay tuned for updates as we work to make this vision a reality! #OhioLifeSciences #Collaboration #Workforce Eddie Pauline, MBA, OhioCED| Bill Dunlevy |Angie McMurry Natalie Monroe| Mandy (Bosse) Medve (Forge Biologics) Michell Ward (Columbus State Community College) Christina Misali (JobsOhio) | Thomas Dyer (Delaware Area Career Center) Tina (Gonzalez) McBride (Sarepta Therapeutics |Victoria Best, Ph.D (AmplifyBio)| Sean Beal (InnoSource)| Dan Zabloudil (InnoSource) Jesse Kwiek (The Ohio State University) | Natalia Kolnik Colvin (Columbus State Community College) | Jim Blythe (InnoSource) | Cheryl Yeack (The Ohio State University)

Join us for Session 6 of our Entrepreneur Workshop Series: Advocacy: A New Potential Model. This session will explore innovative strategies and fresh perspectives on advocacy in the life sciences industry. Speaker: OLS’s Director of Policy, Willa Bluestone ?? Date: 12/16 ?? Time: 2:00 PM – 3:00 PM ?? Location: Virtual ?? Sign up: https://lnkd.in/e26hREJY We look forward to seeing you there! #Networking #Advocacy #OhioLifeSciences

OLS members, streamline your travel! Corporate Traveler USA is a part of our Advantage Purchasing Program.?Get exclusive rates,?dedicated consultants,?24/7 support & more. Contact?[email protected]?for savings! https://lnkd.in/grwGuz3C #OhioLifeSciences #CorporateTravel #AdvantagePurchasingProgram?

We’re excited to celebrate OLS member investor, Abeona Therapeutics,?on the FDA’s acceptance of their Biologics License Application for EB-101, a cell-based?gene therapy for recessive dystrophic epidermolysis bullosa (RDEB)—a rare and severe skin disorder that causes fragile, blistering skin. This is a major step toward bringing relief to patients and advancing cell and gene therapy right here in the Ohio Discovery Corridor! #OhioLifeSciences #CellAndGeneTherapy #Innovation? https://lnkd.in/guQpYjin

Join us on Thursday, November 21?for G2G - Innovative Government Affairs Consulting's Monthly Federal Funding Webinar! This online event is designed for bioscience companies—therapeutics, diagnostics, medical devices, digital health, and more—to explore non-dilutive funding opportunities like grants and BAAs that can fuel your growth. During the first half hour, G2G will share valuable insights from their latest research and host a Q&A. For G2G clients and GBG customers, a deeper dive in the second half-hour will cover federal government funding sources and priority areas, plus offer a tailored consultation. Don’t miss this chance to advance your funding strategy! ???Date:?November 21, 2024 ???Location:?Online ??https://lnkd.in/geB8z87n

We’re excited to announce the appointment of five incredible leaders?to the OLS Board of Directors! These new members bring diverse expertise from across the life sciences industry to guide OLS into 2025 and beyond: ?? Allyson Blandford?(Amgen) ?? Dr. Paco Herson?(The Ohio State University) ?? Greg Kimmel?(Battelle) ?? Liza Lewis, SHRM-CP?(Forge Biologics) ?? Emma Scharfenberger Off?(CincyTech) “OLS is proud to have these dynamic leaders join our distinguished boards, adding to the expertise we are excited to tap into as we continue to deliver for our members and push the life sciences industry forward in our state.” - Eddie Pauline, MBA, OhioCED, president and CEO of OLS. Read the full release:?https://lnkd.in/gYmQPyv3 #OhioLifeSciences #Leadership #Innovation?

Maximizing Your Exit Strategy: Plan for Success ?? Nov 20, 4–6 PM ?? Nuevo Modern Mexican & Tequila Bar, Cleveland, OH Join us for networking and insights on creating a strong exit strategy! Speakers: Michael Triplett, Armatus Bio, Inc. Todd Benni, McDonald Hopkins LLC Jon Snyder, OLS (Moderator) Sponsored by: Ohio Life Sciences, McDonald Hopkins LLC, University Hospitals Ventures, Mercury ?? RSVP: https://lnkd.in/gZUe72g9 #OhioLifeSciences #ExitStrategy #Networking